Home
>
National Drug Code (NDC)
>
LEVITRA
LEVITRA - 0179-0102-08 - (VARDENAFIL HYDROCHLORIDE)
Drug Information of LEVITRA
| Product NDC: | 0179-0102 |
| Proprietary Name: | LEVITRA |
| Non Proprietary Name: | VARDENAFIL HYDROCHLORIDE |
| Active Ingredient(s): | 20 mg/1 & nbsp; VARDENAFIL HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LEVITRA
| Product NDC: | 0179-0102 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021400 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111028 |
Package Information of LEVITRA
| Package NDC: | 0179-0102-08 |
| Package Description: | 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0179-0102-08) |
NDC Information of LEVITRA
| NDC Code | 0179-0102-08 |
| Proprietary Name | LEVITRA |
| Package Description | 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0179-0102-08) |
| Product NDC | 0179-0102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | VARDENAFIL HYDROCHLORIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20111028 |
| Marketing Category Name | NDA |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | VARDENAFIL HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
